Skip to main content

Advertisement

Log in

Personalizing pancreatic cancer organoids with hPSCs

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

A new study using human pluripotent stem cell (hPSC)-derived human pancreatic organoids to model neoplastic transformation and cancer-derived human pancreatic tumor organoids for drug testing provides new personalized approaches to modeling and treating this malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Modeling pancreatic cancer with personalized human organoids.

Katie Vicari/Nature Publishing Group

References

  1. Sato, T. et al. Nature 459, 262–265 (2009).

    Article  CAS  Google Scholar 

  2. Spence, J.R. et al. Nature 470, 105–109 (2011).

    Article  Google Scholar 

  3. Boj, S.F. et al. Cell 160, 324–338 (2015).

    Article  CAS  Google Scholar 

  4. van de Wetering, M. et al. Cell 161, 933–945 (2015).

    Article  CAS  Google Scholar 

  5. Ootani, A. et al. Nat. Med. 15, 701–706 (2009).

    Article  CAS  Google Scholar 

  6. Huang, L. et al. Nat. Med. 21, 1364–1371 (2015).

    Article  CAS  Google Scholar 

  7. Nostro, M.C. et al. Stem Cell Rep. 4, 591–604 (2015).

    Article  CAS  Google Scholar 

  8. Matano, M. et al. Nat. Med. 21, 256–262 (2015).

    Article  CAS  Google Scholar 

  9. Li, X. et al. Nat. Med. 20, 769–777 (2014).

    Article  CAS  Google Scholar 

  10. Drost, J. et al. Nature 521, 43–47 (2015).

    Article  CAS  Google Scholar 

  11. Gao, D. et al. Cell 159, 176–187 (2014).

    Article  CAS  Google Scholar 

  12. Crystal, A.S. et al. Science 346, 1480–1486 (2014).

    Article  CAS  Google Scholar 

  13. Kurian, A.W. Curr. Opin. Obstet. Gynecol. 22, 72–78 (2010).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Calvin J Kuo.

Ethics declarations

Competing interests

C.J.K. is an inventor on a pending patent describing organoid culture methodologies.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, H., Kuo, C. Personalizing pancreatic cancer organoids with hPSCs. Nat Med 21, 1249–1251 (2015). https://doi.org/10.1038/nm.3992

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3992

  • Springer Nature America, Inc.

This article is cited by

Navigation